Catalent Profit Tops Estimates, FY Revenue Guidance Weak; Stock Loses Over 5%

(RTTNews) - Catalent Inc (CTLT) on Wednesday reported fourth-quarter net earnings of $153.7 million or $1.22 per share compared with $27.2 million or $0.36 per share last year.

Excluding income tax benefit and other items, adjusted earnings for the quarter were $0.61 per share compared with $1.01 per share a year ago.

Revenues for the quarter were down at $510.1 million compared with $519.6 million in the prior year.

Analysts polled by Thomson Reuters estimated earnings of $0.58 per share on revenues of $496.9 million for the quarter. Analysts' estimates typically exclude special items.

For the full year 2016, Catalent expects adjusted earnings of $203 million to $226 million and revenues of $1.81 billion to $1.90 billion.

Analysts expect earnings of $1.85 per share on revenues of $1.90 billion for 2016.

Catalent provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products.